Venous thromboembolism in COVID-19 and inherited thrombophilia

Detalhes bibliográficos
Autor(a) principal: Ester Martins Camillozzi Medina
Data de Publicação: 2022
Outros Autores: Daniel Dias Ribeiro, Maria Sueli Silva Namen-Lopes, Suely Meireles Rezende
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFMG
Texto Completo: https://doi.org/10.1016/j.htct.2022.08.001
http://hdl.handle.net/1843/61760
https://orcid.org/0000-0002-5257-9507
Resumo: In December 2019, the first cases of a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2; COVID-19) were detected in Wuhan, China.1 SARS-coV-2 is a highly infectious virus which leads to heterogeneous clinical manifestations.1 Some individuals remain asymptomatic, while others, especially individuals with comorbidities, are more prone to develop severe manifestations of the disease.2 SARSCoV-2 leads to extensive inflammation, endothelial damage, platelet activation and hypercoagulability, characterizing a prothrombotic state.2 Advanced age, diabetes, obesity and hypertension are associated with a higher risk of thromboembolic complications in COVID-19.2 However, little is known about potential interaction between COVID-19 and hereditary thrombophilia and its effect on thrombotic risk.3 Antithrombin (AT) is a physiological inhibitor of coagulation, mainly of thrombin, but also of factors Xa, IXa and others.4 AT deficiency is an autosomal dominant hereditary disorder, with variable penetrance and equal distribution between sexes.4 Patients with AT deficiency are at significantly increased risk of thromboembolism, especially venous (VTE).4 Of all hereditary thrombophilias, AT deficiency is the one with the highest risk of VTE.4 The aim of this article is to report a case of a young man with AT deficiency and prothrombin mutation G20210A who, 7 days after the onset of COVID-19, developed an episode of deep venous thrombosis (DVT) in the right leg.
id UFMG_cf142966f17d83cfaf767b417eb6d085
oai_identifier_str oai:repositorio.ufmg.br:1843/61760
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling 2023-12-05T20:48:56Z2023-12-05T20:48:56Z202213https://doi.org/10.1016/j.htct.2022.08.0012531-1379http://hdl.handle.net/1843/61760https://orcid.org/0000-0002-5257-9507In December 2019, the first cases of a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2; COVID-19) were detected in Wuhan, China.1 SARS-coV-2 is a highly infectious virus which leads to heterogeneous clinical manifestations.1 Some individuals remain asymptomatic, while others, especially individuals with comorbidities, are more prone to develop severe manifestations of the disease.2 SARSCoV-2 leads to extensive inflammation, endothelial damage, platelet activation and hypercoagulability, characterizing a prothrombotic state.2 Advanced age, diabetes, obesity and hypertension are associated with a higher risk of thromboembolic complications in COVID-19.2 However, little is known about potential interaction between COVID-19 and hereditary thrombophilia and its effect on thrombotic risk.3 Antithrombin (AT) is a physiological inhibitor of coagulation, mainly of thrombin, but also of factors Xa, IXa and others.4 AT deficiency is an autosomal dominant hereditary disorder, with variable penetrance and equal distribution between sexes.4 Patients with AT deficiency are at significantly increased risk of thromboembolism, especially venous (VTE).4 Of all hereditary thrombophilias, AT deficiency is the one with the highest risk of VTE.4 The aim of this article is to report a case of a young man with AT deficiency and prothrombin mutation G20210A who, 7 days after the onset of COVID-19, developed an episode of deep venous thrombosis (DVT) in the right leg.engUniversidade Federal de Minas GeraisUFMGBrasilHCL - HOSPITAL DAS CLINICASMED - DEPARTAMENTO DE CLÍNICA MÉDICAHematology, Transfusion and Cell TherapyTromboembolia VenosaCOVID-19Venous thromboembolismInherited thrombophiliaCOVID-19Venous thromboembolism in COVID-19 and inherited thrombophiliainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://www.sciencedirect.com/science/article/pii/S2531137922013074?via%3DihubEster Martins Camillozzi MedinaDaniel Dias RibeiroMaria Sueli Silva Namen-LopesSuely Meireles Rezendeapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/61760/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALVenous thromboembolism in COVID-19 and inherited thrombophilia.pdfVenous thromboembolism in COVID-19 and inherited thrombophilia.pdfapplication/pdf144866https://repositorio.ufmg.br/bitstream/1843/61760/2/Venous%20thromboembolism%20in%20COVID-19%20and%20inherited%20thrombophilia.pdf123a688f6d0c07bce0a14eb29d5eac44MD521843/617602023-12-05 17:48:56.288oai:repositorio.ufmg.br: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Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2023-12-05T20:48:56Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.pt_BR.fl_str_mv Venous thromboembolism in COVID-19 and inherited thrombophilia
title Venous thromboembolism in COVID-19 and inherited thrombophilia
spellingShingle Venous thromboembolism in COVID-19 and inherited thrombophilia
Ester Martins Camillozzi Medina
Venous thromboembolism
Inherited thrombophilia
COVID-19
Tromboembolia Venosa
COVID-19
title_short Venous thromboembolism in COVID-19 and inherited thrombophilia
title_full Venous thromboembolism in COVID-19 and inherited thrombophilia
title_fullStr Venous thromboembolism in COVID-19 and inherited thrombophilia
title_full_unstemmed Venous thromboembolism in COVID-19 and inherited thrombophilia
title_sort Venous thromboembolism in COVID-19 and inherited thrombophilia
author Ester Martins Camillozzi Medina
author_facet Ester Martins Camillozzi Medina
Daniel Dias Ribeiro
Maria Sueli Silva Namen-Lopes
Suely Meireles Rezende
author_role author
author2 Daniel Dias Ribeiro
Maria Sueli Silva Namen-Lopes
Suely Meireles Rezende
author2_role author
author
author
dc.contributor.author.fl_str_mv Ester Martins Camillozzi Medina
Daniel Dias Ribeiro
Maria Sueli Silva Namen-Lopes
Suely Meireles Rezende
dc.subject.por.fl_str_mv Venous thromboembolism
Inherited thrombophilia
COVID-19
topic Venous thromboembolism
Inherited thrombophilia
COVID-19
Tromboembolia Venosa
COVID-19
dc.subject.other.pt_BR.fl_str_mv Tromboembolia Venosa
COVID-19
description In December 2019, the first cases of a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2; COVID-19) were detected in Wuhan, China.1 SARS-coV-2 is a highly infectious virus which leads to heterogeneous clinical manifestations.1 Some individuals remain asymptomatic, while others, especially individuals with comorbidities, are more prone to develop severe manifestations of the disease.2 SARSCoV-2 leads to extensive inflammation, endothelial damage, platelet activation and hypercoagulability, characterizing a prothrombotic state.2 Advanced age, diabetes, obesity and hypertension are associated with a higher risk of thromboembolic complications in COVID-19.2 However, little is known about potential interaction between COVID-19 and hereditary thrombophilia and its effect on thrombotic risk.3 Antithrombin (AT) is a physiological inhibitor of coagulation, mainly of thrombin, but also of factors Xa, IXa and others.4 AT deficiency is an autosomal dominant hereditary disorder, with variable penetrance and equal distribution between sexes.4 Patients with AT deficiency are at significantly increased risk of thromboembolism, especially venous (VTE).4 Of all hereditary thrombophilias, AT deficiency is the one with the highest risk of VTE.4 The aim of this article is to report a case of a young man with AT deficiency and prothrombin mutation G20210A who, 7 days after the onset of COVID-19, developed an episode of deep venous thrombosis (DVT) in the right leg.
publishDate 2022
dc.date.issued.fl_str_mv 2022
dc.date.accessioned.fl_str_mv 2023-12-05T20:48:56Z
dc.date.available.fl_str_mv 2023-12-05T20:48:56Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1843/61760
dc.identifier.doi.pt_BR.fl_str_mv https://doi.org/10.1016/j.htct.2022.08.001
dc.identifier.issn.pt_BR.fl_str_mv 2531-1379
dc.identifier.orcid.pt_BR.fl_str_mv https://orcid.org/0000-0002-5257-9507
url https://doi.org/10.1016/j.htct.2022.08.001
http://hdl.handle.net/1843/61760
https://orcid.org/0000-0002-5257-9507
identifier_str_mv 2531-1379
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Hematology, Transfusion and Cell Therapy
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.publisher.initials.fl_str_mv UFMG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv HCL - HOSPITAL DAS CLINICAS
MED - DEPARTAMENTO DE CLÍNICA MÉDICA
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
bitstream.url.fl_str_mv https://repositorio.ufmg.br/bitstream/1843/61760/1/License.txt
https://repositorio.ufmg.br/bitstream/1843/61760/2/Venous%20thromboembolism%20in%20COVID-19%20and%20inherited%20thrombophilia.pdf
bitstream.checksum.fl_str_mv fa505098d172de0bc8864fc1287ffe22
123a688f6d0c07bce0a14eb29d5eac44
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv
_version_ 1803589575982972928